What Role Does the EMA Play in Approving Cancer Treatments?
The EMA plays a critical role in the approval process of new cancer treatments. After a thorough assessment by the CHMP, the EMA issues a positive opinion, which is then sent to the European Commission for final approval. Once approved, the medicine receives a marketing authorization valid throughout the EU. This centralized procedure ensures that cancer patients across Europe have access to the latest and most effective treatments.
